内抗癌疗法治疗恶性多叶病:事实还是虚构?
Abhinav Agrawal1, Udit Chaddha2, Samira Shojaee3
1Division of Pulmonary, Critical Care and Sleep Medicine, Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York.
Seminars in respiratory and critical care medicine
|June 12, 2023
概括
治疗原发性多发性恶性瘤和恶性多发性溢出是具有挑战性的. 内抗癌疗法作为局部治疗方法具有前景,但需要更多的研究来证实它们与全身选择一起发挥的作用.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 胸部外科手术 胸部外科手术
背景情况:
- 恶性肺病,包括像中瘤和转移性疾病这样的原发性肺病,存在重大管理挑战.
- 传统的治疗方法 (手术,化疗,免疫疗法) 对于原发性多发性恶性瘤的疗效通常是有限的.
- 恶性流需要有效的治疗策略.
研究的目的:
- 审查一次性多发性恶性瘤和恶性多发性溢液的管理.
- 评估内抗癌疗法的当前状态.
主要方法:
- 复习内性化疗,免疫疗法和免疫基因疗法.
- 对性病毒疗法和内药物设备组合的评估.
主要成果:
- 腔空间为局部治疗提供了一个独特的场所.
- 脑内膜内疗法可以作为全身治疗的辅助剂,可能减少副作用.
结论:
- 腔空间提供了一个独特的解剖学部位,用于向的抗癌药物输送.
- 胸腔内膜治疗是治疗恶性胸膜疾病的一个有希望的途径,有可能改善患者的治疗结果.
- 进一步的以患者结果为重点的研究对于确定这些内治疗在临床实践中的最佳作用至关重要.
相关概念视频
Pleural Effusion II: Symptoms and Management
221
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
221
Pleural Disorders: Types and Brief Description
250
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
250
Pleura of the Lungs
2.4K
The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
2.4K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Pneumothorax-II
218
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
218
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K


